Abstract:Back to table of contents Previous article Next article Letters to the EditorFull AccessDown-Regulation of SIRT1 Gene Expression in Major Depressive DisorderXiong-Jian Luo, Ph.D., Chen Zhang, M.D., Ph.D.Xiong-Jian LuoSearch for more papers by this author, Ph.D., Chen ZhangSearch for more papers by this author, M.D., Ph.D.Published Online:1 Oct 2016https://doi.org/10.1176/appi.ajp.2016.16040394AboutSectionsView articleSupplemental MaterialPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleTothe Editor: Major depressive disorder is one of the most prevalent mental health disorders and a leading cause of disability worldwide. Although major depressive disorder has a relatively high heritability, which has been estimated to be around 0.32 (1), the genes contributing to risk of major depressive disorder remain largely unknown. A recent large-scale genome-wide association study (including 5,303 case subjects and 5,337 control subjects) showed that genetic variants near the SIRT1 gene are significantly associated with major depressive disorder (2), suggesting that SIRT1 may play a role in the pathogenesis of major depressive disorder. To test if the dysregulation of SIRT1 has a role in major depressive disorder, we measured the expression level of SIRT1 in subjects with major depressive disorder and in comparison subjects.Fifty unrelated major depressive disorder subjects who were not taking medication and 50 comparison subjects (age and sex-matched) were recruited from Shanghai Mental Health Center, and peripheral blood samples were collected between 7:00 a.m. and 9:00 a.m. from fasting patients and healthy comparison subjects. Detailed information about sample collection, diagnosis, RNA extraction, reverse transcription, real-time quantitative polymerase chain reaction (PCR), and statistical analyses can be found in the data supplement accompanying the online edition of this letter. Glyceraldehyde-3-phosphate dehydrogenase was used as an internal control, and the 2-ΔΔCt method (3) was used to analyze the fold change of quantitative PCR data.We found that SIRT1 expression is significantly down-regulated in the peripheral blood of patients with major depressive disorder compared with comparison subjects (decreased by 37%) (p=3.98×10−8) (Figure 1). To further validate our results, we examined SIRT1 expression in the peripheral blood of major depressive disorder cases and control subjects using data from a recent large-scale major depressive disorder expression study (4). Again, we found that SIRT1 expression is significantly down-regulated in remitted major depressive disorder cases (cases, N=635; control subjects, N=331; p=5.50×10−3) compared with controls. These consistent results suggest that dysregulation of SIRT1 expression may have a role in major depressive disorder. Interestingly, a recent animal model study also found that dysregulation of SIRT1 signaling has a critical role in depression-like behaviors (5). These convergent lines of evidence support the idea that dysregulation of SIRT1 expression may play an important role in major depressive disorder and suggest that SIRT1 may be a potential target for future therapeutics and diagnostics. Although these results suggest an important role for SIRT1 in major depressive disorder, it should be noted that major depressive disorder is most likely a polygenic phenotype and that many other loci remain to be discovered beyond SIRT1.FIGURE 1. Significant Down-Regulation of SIRT1 Expression in Major Depressive Disorderaa Expression of SIRT1 is decreased by 37% in cases of major depressive disorder relative to comparison subjects.From the Key Laboratory of Animal Models and Human Disease Mechanism of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan Province; and the Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.The authors contributed equally to this letter.The authors report no financial relationships with commercial interests.References1 Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157:1552–1562Link, Google Scholar2 CONVERGE consortium: Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523:588–591Crossref, Medline, Google Scholar3 Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402–408Crossref, Medline, Google Scholar4 Jansen R, Penninx BW, Madar V, et al.: Gene expression in major depressive disorder. Mol Psychiatry 2016; 21:339–347Crossref, Medline, Google Scholar5 Abe-Higuchi N, Uchida S, Yamagata H, et al.: Hippocampal sirtuin 1 signaling mediates depression-like behavior. Biol Psychiatry (Epub ahead of print, Jan 30, 2016)Google Scholar FiguresReferencesCited byDetailsCited byResveratrol alleviates postpartum depression-like behavior by activating autophagy via SIRT1 and inhibiting AKT/mTOR pathwayBehavioural Brain Research, Vol. 438Silent information regulator 1 mediates H2S-inhibited chronic restraint stress-induced depressive-like behaviors by regulating hippocampal autophagy26 December 2022 | NeuroReport, Vol. 34, No. 3LncRNA-84277 is involved in chronic pain-related depressive behaviors through miR-128-3p/SIRT1 axis in central amygdala26 July 2022 | Frontiers in Molecular Neuroscience, Vol. 15Sirtuin Type 1 Mediates the Antidepressant Effect of S-Ketamine in a Chronic Unpredictable Stress Model19 May 2022 | Frontiers in Psychiatry, Vol. 13Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions14 February 2022 | Neurotoxicity Research, Vol. 40, No. 2Fat mass and obesity-associated protein regulates RNA methylation associated with depression-like behavior in mice26 November 2021 | Nature Communications, Vol. 12, No. 1Downregulated SIRT1 in the CeA is involved in chronic pain-depression comorbidityBrain Research Bulletin, Vol. 174The Molecular Basis of Depression: Implications of Sex-Related Differences in Epigenetic Regulation1 July 2021 | Frontiers in Molecular Neuroscience, Vol. 14Neurobiologic correlates of depression: illustration of challenges in bench-to-bedside translationRelationship between SIRT1 gene and adolescent depressive disorder with nonsuicidal self-injury behavior6 August 2021 | Medicine, Vol. 100, No. 31Dissecting major depression: The role of blood biomarkers and adverse childhood experiences in distinguishing clinical subgroupsJournal of Affective Disorders, Vol. 276A Comprehensive Analysis of the Effect of SIRT1 Variation on the Risk of Schizophrenia and Depressive Symptoms31 July 2020 | Frontiers in Genetics, Vol. 11Association of a SIRT1 polymorphism with changes of gray matter volume in patients with first-episode medication-naïve major depressionPsychiatry Research: Neuroimaging, Vol. 301Melatonin Act as an Antidepressant via Attenuation of Neuroinflammation by Targeting Sirt1/Nrf2/HO-1 Signaling12 June 2020 | Frontiers in Molecular Neuroscience, Vol. 13Effect of the SIRT1 gene on regional cortical grey matter density in the Han Chinese population20 December 2018 | The British Journal of Psychiatry, Vol. 216, No. 5SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala31 January 2020 | The Journal of Neuroscience, Vol. 40, No. 11 Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway 1 May 2020 | Journal of Inflammation Research, Vol. Volume 13 miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus 1 April 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16Correlations Between SIRT Genetic Polymorphisms and Postpartum Depressive Symptoms in Chinese Parturients Who Had Undergone Cesarean Section1 December 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population9 December 2019 | Translational Psychiatry, Vol. 9, No. 1Altered expression of long noncoding RNAs in patients with major depressive disorderJournal of Psychiatric Research, Vol. 117European Neuropsychopharmacology, Vol. 29Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 95Psychiatry Research, Vol. 278Psychological Medicine, Vol. 49, No. 11Frontiers in Genetics, Vol. 9Frontiers in Immunology, Vol. 10Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapyEuropean Neuropsychopharmacology, Vol. 28, No. 9Evidence supporting a mechanistic role of sirtuins in mood and metabolic disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 86Epigenetic mechanisms of major depression: Targeting neuronal plasticity26 December 2017 | Psychiatry and Clinical Neurosciences, Vol. 72, No. 4CDK5-mediated phosphorylation of Sirt2 contributes to depressive-like behavior induced by social defeat stressBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1864, No. 2Oxidative Medicine and Cellular Longevity, Vol. 2018Frontiers in Neuroscience, Vol. 12 Volume 173Issue 10 October 01, 2016Pages 1046-1046 Metrics KeywordsGeneticsBiological MarkersOther DisordersStressSIRT1 GeneMajor Depressive DisorderPDF download History Accepted 1 June 2016 Published online 1 October 2016 Published in print 1 October 2016

SIRT1 Rs3758391 and Major Depressive Disorder: New Data and Meta-Analysis

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

The Depression GWAS Risk Allele Predicts Smaller Cerebellar Gray Matter Volume and Reduced SIRT1 Mrna Expression in Chinese Population

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Identification of SLC25A37 As a Major Depressive Disorder Risk Gene.

Association of single nucleotide polymorphisms and gene-environment interactions with major depressive disorder in Chinese

The Gene Encoding Protocadherin 9 ( PCDH9 ), a Novel Risk Factor for Major Depressive Disorder

A Comprehensive Analysis of the Effect of SIRT1 Variation on the Risk of Schizophrenia and Depressive Symptoms

Association of APC and REEP5 Gene Polymorphisms with Major Depression Disorder and Treatment Response to Antidepressants in a Han Chinese Population

Common Variants in GRIK4 and Major Depressive Disorder: an Association Study in the Chinese Han Population.

Common SNPs in Myelin Transcription Factor 1-Like (MYT1L): Association with Major Depressive Disorder in the Chinese Han Population.

Association Study of the CRHR1 Gene and Major Depression

Down-Regulation of SIRT1 Gene Expression in Major Depressive Disorder.

Personality traits as mediators in the association between SIRT1 rs12415800 polymorphism and depressive symptoms among Chinese college students

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder

Integrating genome-wide association study and expression quantitative trait loci data identifies <i>NEGR1</i> as a causal risk gene of major depression disorder

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene is Associated with Major Depressive Disorder in the Han Chinese Population.

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated with Antidepressant Efficacy in Major Depressive Disorder

Regulatory Mechanisms of Major Depressive Disorder Risk Variants

Association Study of 5-HT1A, 5-HT2A Polymorphisms with Schizophrenia and Major Depressive Disorder in the Han Chinese Population.